Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 87 peer-reviewed journal articles Updated
Pulmonology

Your Guide to Severe Refractory Eosinophilic Asthma

At a Glance

Severe refractory eosinophilic asthma is a specific type of asthma driven by Type 2 inflammation that does not respond to standard inhaled steroids. Patients often require targeted biologic therapies to control their symptoms and reduce their dependence on oral steroids like prednisone.

Welcome to your comprehensive guide on Severe Refractory Eosinophilic Asthma. Receiving this diagnosis—or suspecting you might have it—can be overwhelming. This guide is designed to empower you with the knowledge you need to partner effectively with your medical team.

Severe refractory eosinophilic asthma is a specific subset of asthma driven by an overactive immune response known as Type 2 inflammation. [1] Unlike standard asthma, it remains uncontrolled despite high doses of inhaled steroids, often leaving patients reliant on harmful oral steroids like prednisone. [2]

In this resource, you will find detailed, evidence-based information across four key areas:

01

Validation & Orientation: Understanding Severe Refractory Eosinophilic Asthma

Learn what severe refractory eosinophilic asthma means. Understand the role of eosinophils, the risks of steroid dependence, and modern biologic treatments.

02

Biology & Differential Diagnosis: Eosinophils, IL-5, and The EGPA Pitfall

Learn the biology behind severe eosinophilic asthma, including the role of IL-5. Understand the red flag symptoms of EGPA and why it gets misdiagnosed.

03

Standard of Care Treatment: Biologics and GINA Guidelines

Learn about biologic treatments for severe eosinophilic asthma based on GINA guidelines. Understand your options, side effects, and steroid tapering safely.

04

Monitoring, Biomarkers & What to Expect: Tracking Your Asthma

Learn how to track severe eosinophilic asthma using biomarkers like blood eosinophil counts and FeNO tests. Understand your path to clinical remission.

Use this guide to learn at your own pace, prepare for your next specialist visit, and confidently advocate for your health.

Common questions in this guide

What is severe refractory eosinophilic asthma?
It is a specific type of asthma driven by an overactive immune response called Type 2 inflammation. It is considered 'refractory' because it remains uncontrolled even when using high doses of standard inhaled steroids.
Why do standard asthma inhalers not work for my severe asthma?
This condition is driven by specific inflammatory cells and pathways, such as eosinophils and IL-5. Standard asthma inhalers often cannot fully control this unique type of inflammation, which is why patients may end up relying on oral steroids.
How do biologic therapies treat eosinophilic asthma?
Biologics are targeted medical therapies designed to block the specific immune pathways that cause eosinophilic asthma. They aim to reduce inflammation, help control your asthma symptoms, and allow you to taper off oral steroids.
How will my doctor monitor my severe asthma over time?
Doctors track your asthma using specific biomarkers found in blood and breath tests. These tests measure your inflammation levels to determine if your current treatment plan is working and if you are moving toward clinical remission.
What is EGPA and how does it relate to my asthma?
EGPA is a separate, related medical condition that can closely mimic the symptoms of severe eosinophilic asthma. Your medical team will evaluate your tests and symptoms to rule out EGPA and ensure you have the correct diagnosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my medical record confirm a diagnosis of severe refractory eosinophilic asthma, or are we still confirming the specific phenotype?
  2. 2.Which of the four main topics in this guide do you think we need to focus on most urgently in my care plan?
  3. 3.Are there any other conditions or lifestyle factors we need to address before labeling my asthma as truly 'refractory'?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Can Wildfire Smoke Stop Asthma Biologics from Working?Do Fasenra or Nucala Protect Against Wildfire Smoke?What If Your Rescue Inhaler Fails During Wildfire Smoke?Why Does Wildfire Smoke Cause a Delayed Asthma Flare-Up?

References

References (2)
  1. 1

    Characteristics, phenotypes, mechanisms and management of severe asthma.

    Chung KF, Dixey P, Abubakar-Waziri H, et al.

    Chinese medical journal 2022; (135(10)):1141-1155 doi:10.1097/CM9.0000000000001990.

    PMID: 35633594
  2. 2

    Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.

    Pelaia C, Vatrella A, Busceti MT, et al.

    Drug design, development and therapy 2017; (11()):3137-3144 doi:10.2147/DDDT.S150656.

    PMID: 29133975

This guide is for informational purposes only and does not replace professional medical advice. Always consult your pulmonologist or allergist before making any changes to your asthma treatment plan.

Get notified when new evidence is published on Severe Refractory Eosinophilic Asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.